Ti 3+ self-doped blue TiO 2 (B) single-crystalline nanorods (b-TR) are fabricated via a simple sol–gelation method, cooperated with hydro-thermal treatment and subsequent in situ treatment method, and afterward annealed at 350 °C in Ar. The structures are characterized by X-ray diffraction (XRD), Raman, X-ray photoelectron spectroscopy (XPS), diffuse reflectance spectroscopy (UV–vis), scanning electron microscopy (SEM), and transmission electron microscopy (TEM). The prepared b-TR with narrow band gap possesses single-crystalline TiO 2 (B) phase, Ti 3+ self-doping, and one-dimensional (1D) rodlike nanostructure. In addition, the improved photocatalytic performance is studied by decomposition of Rhodamine B (RhB) and hydrogen evolution. The degradation rate of RhB by Ti 3+ self-doped blue TiO 2 (B) single-crystalline nanorods is ∼6.9- and 2.1-times higher compared with the rates of titanium dioxide nanoparticles and pristine TiO 2 (B) nanorods under visible light illumination, respectively. The hydrogen evolution rate of b-TR is 26.6 times higher compared with that of titanium dioxide nanoparticles under AM 1.5 irradiation. The enhanced photocatalytic performances arise from the synergetic action of the special TiO 2 (B) phase, Ti 3+ self-doping, and the 1D rod-shaped single-crystalline nanostructure, favoring the visible light utilization and the separation and transportation of photogenerated charge carriers.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: